Immpact Immuno-Information To Shift the Paradigm In Cancer Treatment Trademark Details

This mark is dead with a status of Abandoned-Failure to Respond or Late Response. The last case file activity for this mark occured 16 years ago on Friday, May 16, 2008, according to the United State Patent & Trademark Office
Word Mark Immpact Immuno-Information to Shift the Paradigm in Cancer Treatment
Status Dead 602 — Abandoned-Failure to Respond or Late Response

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77230479
Status Date Friday, May 16, 2008
Filing Date Friday, May 16, 2008
Attorney Nadine P. Flynn

Correspondent

NADINE P. FLYNN
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVE
NEW YORK, NY 10154-0004

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Description of Mark The mark consists of Series of squares in front of word IMMPACT.
Goods & Services Printed materials regarding cancer
Goods & Services Educational and promotional materials regarding cancer
Pseudo Mark Impact Immuno-Information to Shift the Paradigm in Cancer Treatment

Classifications

International Class Codes
016 — Class 16 includes mainly paper, goods made from that material and office requisites.
U.S. Class Codes 002, 005, 022, 023, 029, 037, 038, 050
Status 6 — Active
Status Date Friday, July 20, 2007
Primary Code 016
International Class Codes
041 — Class 41 covers mainly services rendered by persons or institutions in the development of the mental faculties of persons or animals, as well as services intended to entertain or to engage the attention.
U.S. Class Codes 100, 101, 107
Status 6 — Active
Status Date Friday, July 20, 2007
Primary Code 041

You must be signed in to print.

Once signed in, look for the PDF button.